News | January 23, 2012

Virginia Physicians Use Elekta Software to Better Target Moving Liver Tumors

January 23, 2012 — In treatments of the first handful of patients with lung or liver tumors, Riverside and University of Virginia Radiosurgery Center in Newport News, Va., clinicians have demonstrated the benefit that Elekta's Symmetry 4-D image guidance technology provides for patients whose tumors move with their breathing. Symmetry essentially yields a more distinct picture of the tumor, without the blurring associated with breathing motion.

By having a clearer picture of the tumor position and its motion, physicians have been able to improve the targeting of tumors, thereby avoiding having to treat a larger margin of healthy tissue around the lesion. A Symmetry scan is acquired just before treatment to ensure that the patient is correctly positioned, and to visualize tumor movement.

"Symmetry scans give us clearer information about the movement of the tumor, allowing us to increase the safety of treating our patients by decreasing the dose to healthy tissues, while hopefully providing a better clinical outcome," according to Riverside medical physicist Kelly Spencer.

Tumor Motion in Sharper Focus

Before they began using the Symmetry feature in Elekta's XVI package of image-guided radiation therapy (IGRT) tools, Riverside clinicians were using sophisticated XVI 3-D cone beam computed tomography (CBCT) VolumeView CBCT imaging technology integrated with their Elekta Synergy S to image tumors. These pre-treatment scans provide physicians with added confidence in the margins that they have planned. Although seeing a target with IGRT technology such as VolumeView has been a key clinical improvement, the motion still created a blur that encompassed the tumor's range of motion.

"For our current protocol, we would create an ITV [internal target volume] to cover the blur we see on the VolumeView," Spencer said. "We began using Symmetry on a couple of patients with lower lung lesions near the diaphragm where we would expect tumor motion to be an issue. We were actually quite mesmerized by the images Symmetry provided. We could clearly see the actual motion of the delineated tumor with respect to the patient's breathing."

The same Symmetry benefit applied to a recent patient with a liver tumor situated near the diaphragm. In this case, clinicians inferred tumor motion by observing the movement of the liver with the patient's breathing.

"We wanted to use Symmetry to see how the superior border of the liver moved, and what we observed was that it did not move simply superior to inferior – there was almost a rolling pattern to the liver motion," Spencer said. "We knew that the liver didn't necessarily move symmetrically on CBCT scans, but it was harder to appreciate due to motion artifact. This movement probably varies between patients, so that is an excellent reason to use Symmetry to evaluate this motion on a case-by-case basis."

The extent of tumor motion as depicted in a Symmetry scan helps clinicians confirm that the margins around the tumor that they applied during the planning phase are as small as possible, thereby protecting healthy uninvolved tissues.

"For example, The Radiation Therapy Oncology Group SBRT Lung protocol criterion is 1 cm margins superior and inferior on the gross tumor volume," he noted. "With Symmetr,y we can potentially reduce the standard margins and thereby decrease the dose to the uninvolved lung tissues."

Accounting for tumor motion is especially important for patients with lung tumors, as Riverside's protocol calls for beam delivery while the patient is breathing freely.

"Many of our lung cancer patients are older; they often have chronic obstructive pulmonary disease or emphysema, so their shortness of breath and erratic breathing pattern makes them unsuited for breath hold treatments or any sort of gating," Spencer said.

He added that eight out of 10 patients with lung tumors could benefit from a Symmetry scan.

"We are very excited about our future with Symmetry," he said. "We expected to be able to see a clearer picture of tumor motion, but we hadn't appreciated how well we would see the motion in all three dimensions. It hasn't been just superior to inferior tumor motion; Symmetry shows how a tumor can move anterior to posterior or left to right. In that respect, Symmetry has really exceeded our initial expectations."

For more information: www.elekta.com

Related Content

New Data Demonstrates Safety Profile of GammaTile Therapy for Various Brain Tumors
News | Brachytherapy Systems | June 18, 2019
GT Medical Technologies Inc. announced the presentation of clinical data from a prospective study of GammaTile Therapy...
Black Men Less Likely to Adopt Active Surveillance for Low-Risk Prostate Cancer
News | Prostate Cancer | June 17, 2019
A new study reveals black men are less likely than white men to adopt an active surveillance strategy for their...
University Medical Center Groningen Performs First Automatic Log-based Proton Therapy Patient QA
News | Proton Therapy | June 14, 2019
IBA announced the physics team of University Medical Center Groningen (UMCG) in the Netherlands has developed and...
ASTRO Applauds New Prior Authorization Legislation
News | Radiation Therapy | June 07, 2019
The American Society for Radiation Oncology (ASTRO) released a statement applauding Congress’s introduction of...
IBA Dosimetry Launches myQA iON
News | Quality Assurance (QA) | June 07, 2019
IBA (Ion Beam Applications S.A.) announced the launch of myQA iON at the 2019 Particle Therapy Co-Operative Group (...
Study Identifies MRI-Guided Radiation Therapy as Growing Market Segment
News | Image Guided Radiation Therapy (IGRT) | June 06, 2019
Revenues from the magnetic resonance imaging (MRI)-guided radiation therapy systems market exceeded $220 million in...
RefleXion Opens New Manufacturing Facility for Biology-guided Radiotherapy Platform
News | Radiation Therapy | May 31, 2019
RefleXion Medical recently announced the opening of its new manufacturing facility at its headquarters in Hayward,...
Accuray Radixact

Accuray Radixact

Feature | Radiation Therapy | May 29, 2019 | By Jeff Zagoudis
While radiation therapy as a disciplin
Sponsored Content | Case Study | Radiation Therapy | May 29, 2019
The so-called “Grey Tsunami” of baby boomers using healthcare services isn’t taking the Radiation Medicine Program at
Improved Imaging for Prostate Cancer Could Lead to More Effective Treatment

The picture shows that time series signal is extracted from a series of ultrasound frames for classification. Each patch across a number of frames inside the prostate is classified into either cancerous or normal tissue. The image at the lower right corner shows the overall result for those frames. Image courtesy of Pingkun Yan and researchers from NIH, University of British Columbia and Queens University.

News | Ultrasound Imaging | May 28, 2019
Engineers at Rensselaer Polytechnic Institute are working to improve imaging methods in order to make medicine more...